Xcout IntelSign inSubscribe

Neuropace, Inc.

NPCEMedical DevicesMountain View, United States

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Subscribe to see Neuropace, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Neuropace, Inc. at a glance

Neuropace, Inc. is a medical devices company headquartered in Mountain View, United States. It is publicly listed (NPCE) with a market capitalisation of $426.2M. Xcout tracks 18 named people at Neuropace, Inc., including Joel D. Becker (Chief Executive Officer, President & Director). Xcout recorded 45 job postings from Neuropace, Inc. in the last 90 days, naming tools such as Salesforce.

Industry
Medical Devices
Headquarters
Mountain View, United States
Market cap
$426.2M
Employees
220
Ticker
NPCE
Job postings recorded (90 days)
45
Xcout AI Rank
0/100
Xcout Green Rank
0/100

Neuropace, Inc. leadership

  • Joel D. BeckerChief Executive Officer, President & Director
  • Patrick F. WilliamsChief Financial Officer
  • Martha J. MorrellChief Medical Officer
  • Dylan JohnChief of Operations & Development
  • Chris ReeseSenior Vice President of Sales
  • Amy TreadwellVice President of Human Resources

12 more named people on record for Neuropace, Inc., with roles, board committees and tenure — see the full roster →

Neuropace, Inc. funding rounds on record

Every round on record:

DateRoundAmountInvestors
Series B$69.4M—

Some filings are not shown as funding rounds.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Hiring at Neuropace, Inc.

Xcout recorded 45 job postings from Neuropace, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Neuropace, Inc.'s job postings

Salesforce

The weekly hiring trend, the roles and locations behind it — see Neuropace, Inc.'s hiring signals →

Investors

Neuropace, Inc. competitors

A few of Neuropace, Inc.'s closest competitors — see the full list of competitors and alternatives →

Penumbra, Inc.PEN · Medical DevicesAlameda, United States
65% matchPublicAI 2/100 ▼Green 0/100

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Market cap$12.9B
Employees4,700
AzurePythonAWSAnsibleGCP
Penumbra, Inc. competitors & alternatives →

Get Neuropace, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Neuropace, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Neuropace, Inc. in Xcout Intel

  • 18 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • Weekly hiring history and the mix of roles behind it
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →